Cognition Therapeutics: Chardan Capital Raises Buy Rating, PT to $4 from $4.

viernes, 27 de marzo de 2026, 8:17 am ET1 min de lectura
CGTX--

Cognition Therapeutics: Chardan Capital Raises Buy Rating, PT to $4 from $4.

Cognition Therapeutics: Chardan Capital Raises Buy Rating, PT to $4 from $4.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios